AU2003291990A8 - Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof - Google Patents

Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof

Info

Publication number
AU2003291990A8
AU2003291990A8 AU2003291990A AU2003291990A AU2003291990A8 AU 2003291990 A8 AU2003291990 A8 AU 2003291990A8 AU 2003291990 A AU2003291990 A AU 2003291990A AU 2003291990 A AU2003291990 A AU 2003291990A AU 2003291990 A8 AU2003291990 A8 AU 2003291990A8
Authority
AU
Australia
Prior art keywords
nipa
polypeptides
anaplastic lymphoma
lymphoma kinase
interacting partner
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003291990A
Other versions
AU2003291990A1 (en
Inventor
Renyunan Bai
Christian Peschel
Justus Duyster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technische Universitaet Muenchen
Original Assignee
Technische Universitaet Muenchen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universitaet Muenchen filed Critical Technische Universitaet Muenchen
Publication of AU2003291990A1 publication Critical patent/AU2003291990A1/en
Publication of AU2003291990A8 publication Critical patent/AU2003291990A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003291990A 2002-10-25 2003-10-24 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof Abandoned AU2003291990A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42104602P 2002-10-25 2002-10-25
US60/421,046 2002-10-25
EP03005411 2003-03-13
EP03005411.8 2003-03-13
PCT/EP2003/011861 WO2004037858A2 (en) 2002-10-25 2003-10-24 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof

Publications (2)

Publication Number Publication Date
AU2003291990A1 AU2003291990A1 (en) 2004-05-13
AU2003291990A8 true AU2003291990A8 (en) 2004-05-13

Family

ID=32178704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003291990A Abandoned AU2003291990A1 (en) 2002-10-25 2003-10-24 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof

Country Status (2)

Country Link
AU (1) AU2003291990A1 (en)
WO (1) WO2004037858A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3774500A (en) * 1999-03-31 2000-10-16 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; "orfx"
EP1074617A3 (en) * 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
AU7721500A (en) * 1999-09-29 2001-04-30 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
CN1333247A (en) * 2000-07-07 2002-01-30 上海博德基因开发有限公司 Novel polypeptide--human zinc finger protein 55.22 and polynucleotide for encoding said polypeptide

Also Published As

Publication number Publication date
WO2004037858A3 (en) 2004-09-23
AU2003291990A1 (en) 2004-05-13
WO2004037858A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
HK1253918A1 (en) Inhalable epinephrine
AU2003265853A8 (en) Hedgehog antagonists, methods and uses related thereto
IL164302A (en) Substituted benzazoles, compositions and use thereof in the manufacture of a medicament for the inhibition of raf kinase activity
AU2003291310A8 (en) Fused heterocyclic compounds and use thereof
HK1083831A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
AP2223A (en) Pramipexole once-daily dosage form.
IL159015A0 (en) Polypeptides, their preparation and use
AU2002367262A8 (en) Personal user agent
IL160974A0 (en) Piperazine derivatives with ccr1 receptor antagonist activity
AU9684401A (en) Hedgehog antagonists, methods and uses related thereto
HK1060727A1 (en) Antagonists of mcp-1 function and methods of use thereof
HUP0301950A3 (en) Rapid onset formulation, comprising enterically coated pyridoxine hcl and doxylamine succinate
HK1060728A1 (en) Antagonists of mcp-1 function and methods of use thereof
EP1652855A4 (en) Polypeptides having brain -localizing activity and uses thereof
ZA200309286B (en) Reserve battery and its use.
HK1069385A1 (en) Heterocyclic compound and medicinal use thereof
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
HK1057216A1 (en) Plant extracts and alkaloids haing antitussive activity.
HUP0303799A3 (en) 5-membered heterocycles and application thereof as medicaments
AU2003291990A8 (en) Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof
GB2371914B (en) Non-visual user interface
EP1544295A4 (en) Salt-inducible kinases 2 and use thereof
AU2003210062A1 (en) Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof
EP1505074A4 (en) Constitutively active histamine h3 receptor mutants and uses thereof
ZA200403530B (en) Chemokine receptor antagonists and methods of use thereof.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase